Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder (Q43750659)

26 November 2017

Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder (English)

1 reference

26 November 2017

0 references

1 reference

1 reference

Meador-Woodruff JH

1

1 reference

PubMed ID

11576760

26 November 2017

Hogg AJ Jr

series ordinal

2

1 reference

PubMed ID

11576760

26 November 2017

Smith RE

series ordinal

3

1 reference

26 November 2017

1 July 2001

1 reference

26 November 2017

Brain Research Bulletin

1 reference

26 November 2017

55

1 reference

26 November 2017

5

1 reference

26 November 2017

631-640

1 reference

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Increased density of glutamate/N-methyl-D-aspartate receptors in putamen from schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Stable transfection of the NR1 subunit in Chinese hamster ovary cells fails to produce a functional N-methyl-D-aspartate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Properties of [3H]AMPA binding in postmortem human brain from psychotic subjects and controls: increases in caudate nucleus associated with suicide.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Recombinant human NMDA homomeric NR1 receptors expressed in mammalian cells form a high-affinity glycine antagonist binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Cloned glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Nucleus-specific expression of ionotropic glutamate receptor subunit mRNAs and binding sites in primate thalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Amelioration of negative symptoms in schizophrenia by glycine.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Differences in Ca2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Abnormal kainate receptor expression in prefrontal cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Glutamate receptor expression in schizophrenic brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Molecular diversity of glutamate receptors and implications for brain function

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

RNA editing of human kainate receptor subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

RNA Editing of the Glutamate Receptor Subunits GluR2 and GluR6 in Human Brain Tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Block of the N-methyl-D-aspartate receptor by phencyclidine-like drugs is influenced by alternative splicing.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

D-cycloserine adjuvant therapy to molindone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Rat GluR7 and a carboxy-terminal splice variant, GluR7b, are functional kainate receptor subunits with a low sensitivity to glutamate

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

The role of RNA editing in controlling glutamate receptor channel properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: evidence on reversible up-regulation by typical neuroleptics.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Effect of RNA editing and subunit co-assembly single-channel properties of recombinant kainate receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Single-channel properties of recombinant AMPA receptors depend on RNA editing, splice variation, and subunit composition.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

The stanley foundation brain collection and neuropathology consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

10.1016/S0361-9230(01)00523-8

Identifiers

DOI

1 reference

26 November 2017

1 reference

PubMed ID

11576760